PerkinElmer, Inc. (0KHEL) DCF Valuation

PerkinElmer, Inc. (0KHE.L) DCF Valuation

US | Healthcare | Medical - Diagnostics & Research | LSE
PerkinElmer, Inc. (0KHEL) DCF Valuation

Fully Editable: Tailor To Your Needs In Excel Or Sheets

Professional Design: Trusted, Industry-Standard Templates

Investor-Approved Valuation Models

MAC/PC Compatible, Fully Unlocked

No Expertise Is Needed; Easy To Follow

Revvity, Inc. (0KHE.L) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Looking to evaluate PerkinElmer, Inc.'s intrinsic value? Our (0KHEL) DCF Calculator integrates real-world data with extensive customization features, enabling you to refine your forecasts and enhance your investment choices.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020
AY2
2021
AY3
2022
AY4
2023
AY5
2024
FY1
2025
FY2
2026
FY3
2027
FY4
2028
FY5
2029
Revenue 3,782.7 5,067.2 3,311.8 2,750.6 2,755.0 2,634.7 2,519.6 2,409.6 2,304.3 2,203.7
Revenue Growth, % 0 33.95 -34.64 -16.95 0.16197 -4.37 -4.37 -4.37 -4.37 -4.37
EBITDA 1,202.6 1,726.6 1,300.2 713.6 840.3 851.3 814.2 778.6 744.6 712.1
EBITDA, % 31.79 34.07 39.26 25.94 30.5 32.31 32.31 32.31 32.31 32.31
Depreciation 246.5 311.4 427.0 431.8 427.8 299.2 286.1 273.6 261.7 250.3
Depreciation, % 6.52 6.15 12.89 15.7 15.53 11.36 11.36 11.36 11.36 11.36
EBIT 956.1 1,415.1 873.2 281.8 412.4 552.1 528.0 505.0 482.9 461.8
EBIT, % 25.27 27.93 26.37 10.24 14.97 20.96 20.96 20.96 20.96 20.96
Total Cash 402.0 618.3 454.4 1,603.1 1,163.4 722.2 690.7 660.5 631.7 604.1
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1,155.1 707.9 612.8 632.8 632.4
Account Receivables, % 30.54 13.97 18.5 23.01 22.95
Inventories 514.6 624.7 405.5 428.1 367.6 353.5 338.0 323.3 309.1 295.6
Inventories, % 13.6 12.33 12.24 15.56 13.34 13.42 13.42 13.42 13.42 13.42
Accounts Payable 327.3 324.8 272.8 204.1 167.5 193.9 185.4 177.3 169.6 162.2
Accounts Payable, % 8.65 6.41 8.24 7.42 6.08 7.36 7.36 7.36 7.36 7.36
Capital Expenditure -77.5 -99.9 -85.6 -81.4 -86.6 -67.0 -64.0 -61.2 -58.6 -56.0
Capital Expenditure, % -2.05 -1.97 -2.59 -2.96 -3.15 -2.54 -2.54 -2.54 -2.54 -2.54
Tax Rate, % 14.47 14.47 14.47 14.47 14.47 14.47 14.47 14.47 14.47 14.47
EBITAT 767.8 1,042.8 762.4 1,067.4 352.7 471.4 450.8 431.1 412.2 394.2
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -405.5 1,588.9 1,366.2 1,306.5 718.2 802.4 704.9 674.1 644.7 616.5
WACC, % 6.95 6.89 7.01 7.12 6.99 6.99 6.99 6.99 6.99 6.99
PV UFCF
SUM PV UFCF 2,847.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 629
Terminal Value 12,595
Present Terminal Value 8,983
Enterprise Value 11,831
Net Debt 2,139
Equity Value 9,692
Diluted Shares Outstanding, MM 123
Equity Value Per Share 78.91

Benefits of Choosing Us

  • Comprehensive Financial Model: Leverage PerkinElmer's actual data for accurate DCF valuation.
  • Full Control Over Forecasting: Modify revenue growth, profit margins, WACC, and other critical variables.
  • Real-Time Calculations: Automatic updates provide immediate insights as you adjust inputs.
  • Professional-Grade Template: An advanced Excel file crafted for high-quality valuation presentations.
  • Flexible and Reusable: Designed for adaptability, allowing you to conduct detailed forecasts repeatedly.

Key Features

  • Pre-Loaded Data: PerkinElmer, Inc.'s historical financial statements and pre-populated forecasts.
  • Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Results: Instantly view the recalculated intrinsic value for PerkinElmer, Inc. (0KHEL).
  • Clear Visual Outputs: Engaging dashboard charts showcasing valuation results and essential metrics.
  • Designed for Precision: A professional-grade tool tailored for analysts, investors, and finance professionals.

How It Works

  • Step 1: Download the ready-to-use Excel template containing PerkinElmer, Inc.'s (0KHEL) data.
  • Step 2: Review the pre-populated sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth rates, and profit margins).
  • Step 4: Instantly see the updated results, including the intrinsic value of PerkinElmer, Inc. (0KHEL).
  • Step 5: Utilize the outputs to make well-informed investment decisions or create detailed reports.

Why Choose PerkinElmer's Solutions?

  • Streamlined Workflow: No need to build a model from the ground up – our tools are ready to go.
  • Enhanced Precision: Dependable data and methodologies minimize errors in your analysis.
  • Fully Adaptable: Customize our platform to align with your specific needs and forecasts.
  • User-Friendly Interface: Intuitive visuals and outputs facilitate easy interpretation of results.
  • Backed by Professionals: Developed for experts who prioritize accuracy and efficiency.

Who Should Utilize This Product?

  • Professional Investors: Develop comprehensive and trustworthy valuation models for investment portfolio evaluations.
  • Corporate Finance Teams: Examine valuation scenarios to inform and shape corporate strategy.
  • Consultants and Advisors: Deliver precise valuation insights for PerkinElmer, Inc. (0KHEL) to your clients.
  • Students and Educators: Leverage real-world data for practice and instruction in financial modeling.
  • Life Science Enthusiasts: Gain insights into how companies like PerkinElmer, Inc. (0KHEL) are assessed in the marketplace.

Overview of Template Components

  • Historical Data: Provides a comprehensive overview of PerkinElmer’s past financial performance and foundational forecasts.
  • DCF and Levered DCF Models: In-depth templates for assessing the intrinsic value of PerkinElmer.
  • WACC Sheet: Pre-configured calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Adjust essential parameters such as growth rates, EBITDA percentages, and CAPEX projections.
  • Quarterly and Annual Statements: A thorough analysis of PerkinElmer’s financial reports.
  • Interactive Dashboard: Dynamic visualization of valuation outcomes and forecasts.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.